PHARMAGEST INTERACTIVE : finalization of its majority shareholding in the capital of the company DIATELIC

Villers Les Nancy, FRANCE


Villers-lès-Nancy, 5 March 2012 - 18h00 (CET)

PRESS RELEASE

PHARMAGEST INTERACTIVE announces the finalization of its majority shareholding in the capital of the company DIATELIC

After taking up a minority shareholding of the capital of the innovative French company DIATELIC in December 2010, the PHARMAGEST Group, the French leader in pharmacy information technology, this evening announces that it has carried out the finalization of its majority shareholding in DIATELIC's capital.

From now on, PHARMAGEST INTERACTIVE holds 68.58% of the capital of this innovative company, which specialises in artificial intelligence and expert systems predictive of the evolution of the health of the patients.

This operation falls within the PHARMAGEST Group's continuous strategy aiming, firstly, to consolidate its position as market leader in pharmacy information technology and secondly, to effectively support pharmacists in order that they can fully dedicate themselves to their new missions of providing support and advice to patients. 

About the Pharmagest Group:
The PHARMAGEST Group is the French leader in pharmacy information technology, with 43.5% of market share, 9,800 clients and more than 700 staff. Since September 2007, the PHARMAGEST Group has also been enjoying a presence in Northern Europe with 12% market share in Belgium and Luxembourg.

The favoured partner of pharmacists for more than 25 years, the PHARMAGEST Group creates innovative information technology solutions for pharmacies, and develops E-Business E-Media activity with great potential for laboratories.

The PHARMAGEST Group is also developing new software solutions for care homes and day centres for the elderly, through its subsidiary MALTA Informatique.

The first Integrated Portal Management Software (LGPI Global Services ®), creating entries for the patient, the pharmacist and the laboratory, boosts sales, optimizes purchases and enhances patient advice. It is also the first permanent impact medium for pharmacies, supplying laboratories with direct communication towards the pharmacist and his patients. 

Listed on NYSE Euronext Paris(TM) - Compartment C  - CAC ® SMALL90 and CAC ® All-Tradable by inclusion
ISIN: FR 0000077687 - Reuters: PHA.PA - Bloomberg: - PMGI FP  

Find out the latest news from the PHARMAGEST Group at www.pharmagest.com

Contacts: 

Analyst and Investor Relations: 

Financial and Administrative Director Jean-Yves SAMSON

Tel. 03 83 15 90 67 - jean-yves.samson@pharmagest.com

Press Relations: 

FIN'EXTENSO Isabelle APRILE  

Tel. 01 39 97 61 22 - i.aprile@finextenso.fr 


Attachments

Pharmagest - Majority Diatelic